Verbio (VBK) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
19 May, 2026Executive summary
Strong Q3 and nine-month performance driven by robust GHG quota demand, improved market conditions, and record biomethane and bioethanol production.
Ramp-up of Nevada and South Bend plants contributed to higher production and earnings.
Regulatory support, including German Bundesrat approval for significant GHG quota increases by 2040 and RED III implementation, strengthened sector outlook.
Positive free cash flow and improved operating momentum, with net financial debt reduced and equity ratio increased.
Financial highlights
Revenue for the first nine months rose 17% year-over-year to EUR 1,340.7 million, driven by higher production and GHG quota demand.
EBITDA for the nine months surged to EUR 105.7 million from EUR 22.4 million year-over-year, with Q3 EBITDA at EUR 60.2 million.
EBIT for the nine months was EUR 58.3 million, compared to a loss of EUR 24.2 million year-over-year.
Operating cash flow for nine months was EUR 96.4 million, with free cash flow at EUR 33.0 million after EUR 63.4 million in PPE investments.
Net financial debt reduced to EUR 126.8 million; equity ratio improved to 59.3%.
Outlook and guidance
EBITDA guidance for FY 2025/26 raised to the upper end of EUR 100–140 million, reflecting strong market and regulatory support.
Net financial debt expected to be below EUR 140 million by year-end; net debt/EBITDA targeted below 1x.
Production capacity utilization expected to increase year-over-year across all segments.
Ongoing regulatory changes and geopolitical factors continue to influence the outlook and forecast range.
Latest events from Verbio
- Profitability rebounds as regulatory clarity, innovation, and global expansion drive growth.VBK
German Select VII Conference15 Apr 2026 - Revenue up 19% and EBITDA tripled, driven by higher production and GHG quota demand.VBK
Q2 25/2612 Apr 2026 - Record biofuel output and growth investments set stage for higher EBITDA in FY 2024/25.VBK
Q4 23/2420 Jan 2026 - EBITDA and revenue fell, but guidance and regulatory support remain positive for FY 2024/25.VBK
Q1 24/2514 Jan 2026 - EBITDA and revenue fell, but Q2 rebounded and guidance was cut amid market and technical headwinds.VBK
Q2 24/2516 Dec 2025 - EBITDA and revenue fell, but production hit records; guidance and CapEx were cut.VBK
Q3 24/2518 Nov 2025 - Revenue up 22%, EBITDA surged, and outlook for FY 2025/2026 remains strong.VBK
Q1 25/2612 Nov 2025 - EBITDA fell on weaker margins and impairment, but outlook is positive with rising global demand.VBK
Q4 24/2525 Sep 2025